Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 1-10 of 14

Page
per page
  1. SID 26681509
    A4424 SID 26681509
    Target: Cathepsins
    Summary: Human cathepsin L inhibitor,potent and reversible
      <26.98 mg/mL
  2. Saxagliptin
    A8650 Saxagliptin
    Target: DPP-4
    Summary: Selective DPP4 inhibitor
  3. UAMC 00039 dihydrochloride
    B5780 UAMC 00039 dihydrochloride
    Target: Dipeptidyl-peptidase II
    Summary: dipeptidyl peptidase II (DPP-II) inhibitor
      ≥133.6 mg/mL
  4. Leupeptin, Microbial
    A2570 Leupeptin, Microbial
    Target: Cathepsins|Calpains|Trypsins
    Summary: Inhibitor of serine and cysteine proteases
      ≥24.7 mg/mL
  5. Cathepsin G Inhibitor I
    A8174 Cathepsin G Inhibitor I
    Target: Cathepsins
    Summary: Cathepsin G inhibitor
      ≥10.35 mg/mL
  6. Semagacestat (LY450139)
    A8190 Semagacestat (LY450139)
    Summary: γ-secretase inhibitor
      insoluble in H2O; ≥18.05 mg/mL
  7. MK-0752
    A4006 MK-0752
     1 Citation
    Summary: γ-secretase inhibitor
      ≥22.15 mg/mL
  8. BIBR 953 (Dabigatran, Pradaxa)
    A4077 BIBR 953 (Dabigatran, Pradaxa)
    Summary: Thrombin inhibitor,potent,reversible and direct
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O
  9. MG-132
    A2585 MG-132
     26 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor, Cell permeable, reversible
      ≥23.78 mg/mL
  10. GM 6001
    A4050 GM 6001
     2 Citation
    Target: MMP
    Summary: Broad spectrum MMP inhibitor
      insoluble in H2O; insoluble in EtOH; ≥19.42 mg/mL

Items 1-10 of 14

Page
per page